Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Personalized medicine strategies for managing patients with parkinsonism and cognitive deficits.

Metabolism: clinical and experimental - 1 Jan 2013

Wurtman Richard J

Abstract excerpt

Patients exhibiting the classic manifestations of parkinsonism - tremors, rigidity, postural instability, slowed movements and, sometimes, sleep disturbances and depression - may also display severe cognitive disturbances. All of these particular motoric and behavioral symptoms may arise from Par...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha-Synuclein
Share to Antiparkinson Agents
Share to Diagnostic Imaging

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Frontotemporal Dementia

Share to Glucosylceramidase

Share to Leucine-Rich Repeat Serine-Threonine Protein Kinase-2

Share to Levodopa

Share to Lewy Body Disease

Source

Identifiers

PMID: 22999712
DOI: 10.1016/j.metabol.2012.08.025

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22999712-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Personalized medicine strategies for managing patients with parkinsonism and cognitive deficits.PMID 22999712Read ↗

Precision medicine for Parkinson’s disease: The subtyping challengeSemantic proximity Read ↗

Precision medicine for disease modification in Parkinson diseaseSemantic proximity Read ↗

Precision medicine: Clarity for the clinical and biological complexity of Alzheimer's and Parkinson's diseases.Semantic proximity Read ↗

Precision Medicine: Clarity for the Complexity of Dementia.Semantic proximity Read ↗

Modeling Parkinson's Disease Heterogeneity to Accelerate Precision Medicine.Semantic proximity Read ↗

Emerging Targeted Therapeutics for Genetic Subtypes of Parkinsonism.Semantic proximity Read ↗

Parkinson’s disease treatment: past, present, and futureSemantic proximity Read ↗

The role of pharmacogenomics in the personalization of Parkinson's disease treatment.Semantic proximity Read ↗

A Systematic Review of Parkinson's Disease Pharmacogenomics: Is There Time for Translation into the Clinics?Semantic proximity Read ↗

Promising disease-modifying therapies for Parkinson's disease.Semantic proximity Read ↗

Precision medicine in Parkinson's disease: emerging treatments for genetic Parkinson's disease.Semantic proximity Read ↗

Challenges in the diagnosis of Parkinson's diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.